FDA Approvals
- FDA Clearance for Avian Influenza A Rapid Test
- Escitalopram Approved for Treatment of Major Depressive Disorder in Adolescents
- FDA Approves Photopheresis System for Cutaneous T-Cell Lymphoma
- FDA Approves FC2 Female Condom
- FDA Approves Genetic Test for Identifying Human Papillomavirus
- Expanded Indication Approved for Peginterferon-Based Combination Therapy
- FDA Approves Prefilled Disposable Insulin Pen
- FDA Approves New Deep Brain Stimulation Device for OCD
- FDA Approvals: Kapidex and ATryn
- FDA Approves Febuxostat for Management of Hyperuricemia in Those With Gout
- FDA Approves Calcitriol Ointment for Psoriasis
- FDA Approves Human Fibrinogen Concentrate for Treatment of Bleeding
- FDA Approves Milnacipran for Fibromyalgia
- FDA Approves Tramadol Extended-Release Formulation for Chronic Pain
- FDA Approves First Nucleic Acid Test to Screen for 2 Divergent HIV Types
- FDA Approves Gleevec for Gastrointestinal Stromal Tumor
- FDA Approves Plerixafor to Improve Stem Cell Mobilization
- FDA Approves Rufinamide in Lennox-Gastaut Syndrome
- FDA Approves Tapentadol for Moderate to Severe Acute Pain
- FDA Approves Focalin XR for ADHD